← Back to Search

Mobile App for Ovarian Cancer Treatment Guidance (VIRGO Trial)

N/A

Recruiting

Led By Tiffany Lai, MD

Research Sponsored by Jonsson Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with ovarian cancer, fallopian tube, or primary peritoneal cancer

Female ≥18 years of age at Screening Visit

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

VIRGO Trial Summary

This trial will test a mobile app that uses patient data to help doctors provide better care for people with advanced ovarian, fallopian tube, and primary peritoneal cancer.

Who is the study for?

This trial is for women aged 18 or older with advanced ovarian, fallopian tube, or primary peritoneal cancer. Participants must be undergoing or about to start treatment within 30 days and have access to an iOS or Android smartphone. Those with other active cancers or conditions that could risk safety/data quality can't join.Check my eligibility

What is being tested?

The study tests a mobile app designed to improve health outcomes by tracking patient-reported data alongside clinical information from medical records, aiming to enhance the care team's decision-making during treatments like chemotherapy.See study design

What are the potential side effects?

Since this trial involves using a mobile application rather than medication, traditional side effects are not expected. However, participants may experience issues related to privacy concerns, data security, and potential stress from constant health monitoring.

VIRGO Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with ovarian, fallopian tube, or peritoneal cancer.

Select...

I am a woman aged 18 or older.

VIRGO Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Assessment of the NFOSI-18 Function/Well-being subscale score between study groups

Secondary outcome measures

Comparison of adverse events (including medication side-effects)

Comparison of medication adherence (Adherence Index)

Comparison of patient activation scores (PAM-13)

+4 more

VIRGO Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Interventional ArmExperimental Treatment1 Intervention

Use of Mobile Application

Group II: Control ArmActive Control1 Intervention

Routine care and symptom management

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San FranciscoOTHER

2,507 Previous Clinical Trials

15,238,375 Total Patients Enrolled

6 Trials studying Ovarian Cancer

1,604 Patients Enrolled for Ovarian Cancer

University of California, San DiegoOTHER

1,122 Previous Clinical Trials

1,520,844 Total Patients Enrolled

Jonsson Comprehensive Cancer CenterLead Sponsor

361 Previous Clinical Trials

27,612 Total Patients Enrolled

5 Trials studying Ovarian Cancer

12 Patients Enrolled for Ovarian Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I qualify to partake in this research endeavor?

"This medical trial is seeking 200 willing participants aged 18 to 90 with a confirmed diagnosis of ovarian cancer, who are currently receiving or will soon begin treatment. In addition, these patients must have access to an IOS or Android-based smart phone and provide documented consent for their participation in the study."

Answered by AI

Is there an ongoing recruitment of participants for this experiment?

"Affirmative, clinicaltrials.gov data affirms this medical trial is presently seeking participants. It was originally published on October 17th 2023 and last revised November 16th 2023; 200 patients are required from one site."

Answered by AI

Does this trial accept participants younger than 65 years old?

"To qualify for this medical trial, individuals must be between 18 and 90 years old. This study is not accessible to those under 18, while 675 participants who are over 65 have been admitted."

Answered by AI

What is the current limit for participants in this medical research endeavor?

"Affirmative. According to clinicaltrials.gov, this research project has been actively recruiting since October 17th 2023 and was updated last on November 16th 2023. 200 individuals are required for the study at one specific trial site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)

2023. "Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05523700.